Bindex for Osteoporosis Diagnostics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

293 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-11

Study Completion Date

2020-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that over 75% of osteoporotic patients are not diagnosed and does not receive treatment for their condition. Bindex ultrasound device has been developed and validated in Caucasian female population. In this study, diagnostic thresholds for density index as determined with Bindex will be evaluated in two different ethnic populations.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX

NCT01998737

Osteoporosis

COMPLETED

Bindex Ultrasonometer for Osteoporosis Diagnostics

NCT01935232

Osteoporosis

TERMINATED

Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer

NCT01978834

Osteoporosis

COMPLETED

Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability

NCT05721898

Osteoporosis Osteopenia or Osteoporosis Osteoporosis, Postmenopausal +4 more

COMPLETED

Immunophenotyping in Patients With Osteoporosis

NCT05132348

Immunophenotyping Blood Samples of Patients With Osteoporosis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, the diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD), using axial dual energy X-ray absorptiometry (DXA) of the hip and/or the lumbar spine at special healthcare.

Application of diagnostic thresholds determined against BMD have been suggested by International Society for Clinical Densitometry (ISCD) for use with peripheral bone densitometry devices (90% sensitivity and 90% specificity). These thresholds have been determined and validated for Bindex in Caucasian female population.

This study focuses on clinical validation of the ultrasound device (Bindex®, Bone Index Finland Ltd., www.boneindex.com) device and Density Index (DI), a diagnostic parameter reported by Bindex. The predetermined thresholds for DI will be evaluated by measuring 70 osteoporotic and 70 healthy patients with Bindex and DXA in each selected patient groups. The feasibility of DI for diagnostics of osteoporosis in these groups will be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis, Postmenopausal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caucasian female

Bindex measurement

Intervention Type DIAGNOSTIC_TEST

One time bone density measurement with ultrasound device

Hispanic female

Bindex measurement

Intervention Type DIAGNOSTIC_TEST

One time bone density measurement with ultrasound device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bindex measurement

One time bone density measurement with ultrasound device

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postmenopausal status
* Age at 50 years or over
* Caucasian or Hispanic race (number shall be controlled, 140 in each group)
* Body mass index (BMI \< 35)

Additional criteria for Osteoporotic group

\- T-Score (NHANES database) -2.5 or lower at femoral neck or total femur

Additional criteria for non-osteoporotic group

\- T-Score (NHANES database) \> -2.5 at femoral neck or total femur